Literature DB >> 26908057

A Model to Predict the Risk of Keratinocyte Carcinomas.

David C Whiteman1, Bridie S Thompson2, Aaron P Thrift3, Maria-Celia Hughes2, Chiho Muranushi4, Rachel E Neale2, Adele C Green5, Catherine M Olsen2.   

Abstract

Basal cell and squamous cell carcinomas of the skin are the commonest cancers in humans, yet no validated tools exist to estimate future risks of developing keratinocyte carcinomas. To develop a prediction tool, we used baseline data from a prospective cohort study (n = 38,726) in Queensland, Australia, and used data linkage to capture all surgically excised keratinocyte carcinomas arising within the cohort. Predictive factors were identified through stepwise logistic regression models. In secondary analyses, we derived separate models within strata of prior skin cancer history, age, and sex. The primary model included terms for 10 items. Factors with the strongest effects were >20 prior skin cancers excised (odds ratio 8.57, 95% confidence interval [95% CI] 6.73-10.91), >50 skin lesions destroyed (odds ratio 3.37, 95% CI 2.85-3.99), age ≥ 70 years (odds ratio 3.47, 95% CI 2.53-4.77), and fair skin color (odds ratio 1.75, 95% CI 1.42-2.15). Discrimination in the validation dataset was high (area under the receiver operator characteristic curve 0.80, 95% CI 0.79-0.81) and the model appeared well calibrated. Among those reporting no prior history of skin cancer, a similar model with 10 factors predicted keratinocyte carcinoma events with reasonable discrimination (area under the receiver operator characteristic curve 0.72, 95% CI 0.70-0.75). Algorithms using self-reported patient data have high accuracy for predicting risks of keratinocyte carcinomas.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 26908057     DOI: 10.1016/j.jid.2016.02.008

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

Review 1.  Genome-wide association studies and polygenic risk scores for skin cancer: clinically useful yet?

Authors:  M R Roberts; M M Asgari; A E Toland
Journal:  Br J Dermatol       Date:  2019-07-07       Impact factor: 9.302

2.  Quantifying the Polygenic Contribution to Cutaneous Squamous Cell Carcinoma Risk.

Authors:  Joanne E Sordillo; Peter Kraft; Ann Chen Wu; Maryam M Asgari
Journal:  J Invest Dermatol       Date:  2018-02-13       Impact factor: 8.551

3.  Predicting keratinocyte carcinoma in patients with actinic keratosis: development and internal validation of a multivariable risk-prediction model.

Authors:  S Tokez; M Alblas; T Nijsten; L M Pardo; M Wakkee
Journal:  Br J Dermatol       Date:  2020-02-26       Impact factor: 9.302

4.  Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial.

Authors:  Deonna M Ackermann; Amelia K Smit; Monika Janda; Cathelijne H van Kemenade; Mbathio Dieng; Rachael L Morton; Robin M Turner; Anne E Cust; Les Irwig; Jolyn K Hersch; Pascale Guitera; H Peter Soyer; Victoria Mar; Robyn P M Saw; Donald Low; Cynthia Low; Dorothy Drabarek; David Espinoza; Jon Emery; Peter Murchie; John F Thompson; Richard A Scolyer; Anthony Azzi; Alister Lilleyman; Katy J L Bell
Journal:  Trials       Date:  2021-05-04       Impact factor: 2.279

5.  Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.

Authors:  Niina Korhonen; Leea Ylitalo; Tiina Luukkaala; Julius Itkonen; Henni Häihälä; Juha Jernman; Erna Snellman; Johanna Palve
Journal:  Arch Dermatol Res       Date:  2020-08-09       Impact factor: 3.017

6.  Development and Validation of a Simple Model to Predict the Risk of Nonmelanoma Skin Cancer on Screening Total Body Skin Examination.

Authors:  Rebecca I Hartman; Yun Xue; Ryan Karmouta; Elizabeth Tkachenko; Sara J Li; David G Li; Cara Joyce; Arash Mostaghimi
Journal:  Dermatol Res Pract       Date:  2022-08-16

7.  Cutaneous Human Papillomaviruses and the Risk of Keratinocyte Carcinomas.

Authors:  Dana E Rollison; Rossybelle P Amorrortu; Yayi Zhao; Jane L Messina; Michael J Schell; Neil A Fenske; Basil S Cherpelis; Anna R Giuliano; Vernon K Sondak; Michael Pawlita; Sandrine McKay-Chopin; Tarik Gheit; Tim Waterboer; Massimo Tommasino
Journal:  Cancer Res       Date:  2021-07-15       Impact factor: 12.701

Review 8.  Photodynamic Therapy for Basal Cell Carcinoma: The Clinical Context for Future Research Priorities.

Authors:  Nicholas J Collier; Lesley E Rhodes
Journal:  Molecules       Date:  2020-11-18       Impact factor: 4.411

9.  Developing a risk prediction model for keratinocyte carcinoma in patients with actinic keratosis.

Authors:  Y Kim; E Jorgenson; M M Asgari
Journal:  Br J Dermatol       Date:  2020-05-10       Impact factor: 9.302

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.